![Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2119035701/2088332348/ybbmt54880-fig-0001.jpg)
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
![Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2119035240/2088325543/ybbmt54827-fig-0001.jpg)
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation
![Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/76668e97-250b-49cd-bfd4-251e40bff853/cncr31646-fig-0002-m.jpg)
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library
![Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation | Article - Cureus Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation | Article - Cureus](https://assets.cureus.com/uploads/figure/file/185540/article_show_7021f4d0626311eb98bafb0a14d164b4-FIG-1-DE-SHarp.webp)
Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation | Article - Cureus
![Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/a81f8c51-c874-4749-968c-9506e367ab41/cncr31646-fig-0001-m.jpg)
Double hit and double expressors in lymphoma: Definition and treatment - Riedell - 2018 - Cancer - Wiley Online Library
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment](https://www.mdpi.com/diagnostics/diagnostics-12-01087/article_deploy/html/images/diagnostics-12-01087-g005.png)
Diagnostics | Free Full-Text | Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment
![Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram](https://www.researchgate.net/publication/282046248/figure/fig1/AS:499557352079360@1496115162692/Kaplan-Meier-curves-of-progression-free-survival-and-overall-survival-Progression-free.png)
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram
![Altered pathways and targeted therapy in double hit lymphoma | Journal of Hematology & Oncology | Full Text Altered pathways and targeted therapy in double hit lymphoma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01249-9/MediaObjects/13045_2022_1249_Fig1_HTML.png)
Altered pathways and targeted therapy in double hit lymphoma | Journal of Hematology & Oncology | Full Text
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be97aebbcd2be272d04201fac48ca772d19398c5/7-Figure2-1.png)
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar
![Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to Develop Effective New Therapies Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to Develop Effective New Therapies](https://dailynews.ascopubs.org/do/10.1200/ADN.19.190191/full/media/am19_ee_molecular_figure-1564180355887.jpg)
Exploiting the Molecular Heterogeneity of Aggressive B-Cell Lymphomas to Develop Effective New Therapies
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![PFS (A) and OS (B) of patients divided into two groups according to MYC... | Download Scientific Diagram PFS (A) and OS (B) of patients divided into two groups according to MYC... | Download Scientific Diagram](https://www.researchgate.net/publication/339889399/figure/fig3/AS:868426331463682@1584060380721/PFS-A-and-OS-B-of-patients-divided-into-two-groups-according-to-MYC-and-BCL-2-or.png)
PFS (A) and OS (B) of patients divided into two groups according to MYC... | Download Scientific Diagram
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients | Haematologica
![Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0320-9/MediaObjects/41375_2018_320_Fig1_HTML.png)
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
![Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12288-019-01248-w/MediaObjects/12288_2019_1248_Fig3_HTML.png)
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | SpringerLink
![Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2017.93/MediaObjects/41379_2017_Article_BFmodpathol201793_Fig3_HTML.jpg)